All Comments by Elliott Mufson

  1. Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells.
  2. Acetylcholine, aging, and Alzheimer's disease.
  3. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
  4. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.
  5. The mean A beta load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease.
  6. Potent inhibition of interleukin-6 expression in a human astrocytoma cell line by tenidap.
  7. Interfamilial and intrafamilial phenotypic heterogeneity in familial Alzheimer's disease.
  8. ApoE genotype does not affect plasma tPA and PAI-1 antigen levels.
  9. High density lipoprotein decreases beta-amyloid toxicity in cortical cell culture.
  10. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density.
  11. Comparison of site specific injections into the basal forebrain on water maze and radial arm maze performance in the male rat after immunolesioning with 192 IgG saporin.
  12. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide.
  13. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.
  14. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages.
  15. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.